The medical device industry argues that risk-based payment models are pushing providers out of their traditional roles as advocates on behalf of patients for access to new technology and aligning them with insurers as gatekeepers on cost. Hear from Covidien CEO Jose Almeida, AdvaMed CEO Stephen Ubl, Cigna National Medical Officer Dr. Scott Josephs, Premier CEO Susan DeVore and NorthShore University HealthSystem CEO Mark Neaman.
Video: Debating the value of innovation
AdvaMed CEO Stephen Ubl (left) and Covidien CEO Jose Almeida, who serves as the trade group's chairman.
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You
Sponsored Content